Vaccine News and Research

Latest Vaccine News and Research

Swedish study reveals how long immunity lasts after mild COVID

As a result of the ongoing pandemic of the severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) and its associated disease, the coronavirus disease 2019 (COVID-19), the global public health at risk has never been more dire.

27 Jun 2021

Oxford study sheds light on level of antibodies needed to protect against COVID-19 symptoms

Researchers in the UK have reported on the relationship between humoral (antibody) responses and protection against infection with severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) following immunization with AstraZeneca’s ChAdOx1 vaccine.

27 Jun 2021

Lambda lineage of SARS-CoV-2 has potential to become variant of concern

Researchers have described the first reported infection with the C.37 (Lambda) lineage of severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) in Southern Brazil.

27 Jun 2021

Georgia Tech’s dashboard breaks down Covid-19 vaccination trends by race at county level

The U.S. continues to see Covid-19 vaccinations gradually increasing nationwide, with nearly 66% of all adults now having at least one vaccine dose according to CDC's COVID Data Tracker, yet disparities have been noted in vaccination rates across races and geographic areas.

25 Jun 2021

New insights on how an important class of immune receptors are activated

Scientists from within the Antibody and Vaccine Group at the University of Southampton have gained novel insights into how an important class of immune receptors called tumour necrosis factor receptors (TNFR) are activated.

25 Jun 2021

Structural studies of SARS-CoV-2 spike protein reveal new properties of Alpha and Beta variants

New SARS-CoV-2 variants are spreading rapidly, and there are fears that current COVID-19 vaccines won't protect against them.

25 Jun 2021

New positive data on BCG’s ability to safely and significantly lower blood sugars

At the recent 2021 Annual Scientific Sessions of the American Diabetes Association, researchers from Massachusetts General Hospital (MGH) presented positive updates on their trials of the bacillus Calmette-Guérin (BCG) vaccine to safely and significantly lower blood sugars.

25 Jun 2021

Researchers determine molecular structure of bacterial protein complex critical for tuberculosis

Tuberculosis is one of the top ten causes of death worldwide, infecting about one-quarter of the world's population. Although it is treatable, the rise of multidrug-resistant tuberculosis poses a major threat to global health security, and has been declared by the World Health Organization as a global health emergency.

25 Jun 2021

UNC study provides important information for developing a viable vaccine against dengue

Developing a viable vaccine against dengue virus has proved difficult because the pathogen is actually four different virus types, or serotypes. Unless a vaccine protects against all four, a vaccine can wind up doing more harm than good.

25 Jun 2021

Novel biosensor offers rapid quantitative variant of concern-independent serology for SARS-CoV-2

Even as herculean efforts are being made to extend the reach of vaccination against COVID-19 to all the regions of the world, there is a dire need for rapid and sensitive tests to assess the antibody response to the various vaccines used and to monitor antibody titers over time. A new preprint describes a new approach to this problem which could be applied to other molecules of interest as well, both in laboratories and at the point of care.

25 Jun 2021

Study examines safety of COVID-19 vaccination during lactation

A new preprint, recently released on the medRxiv* server, reports from real life in a cohort of mother-child dyads in Singapore. The mothers were lactating after having received COVID-19 vaccination.

25 Jun 2021

The WHO didn’t reverse its position on kids and Covid vaccines

A social media post circulating on Facebook and Instagram claims that the World Health Organization recently flipped its policy recommendation about children receiving a Covid-19 vaccine.

25 Jun 2021

Evaluation of COVID-19 vaccination effects on outbreak dynamics in Japan

Among the developed nations, Japan was the last to commence vaccination (February 2021). Only 8.7% of Japanese people are fully vaccinated as of today, June 25th, 2021. Fortunately for Japan, the incidence of the disease has been much lower than in Europe or the United States. Now, a new study published on the medRxiv* preprint server analyzes the impact of vaccination on the COVID-19 outbreak in Japan

25 Jun 2021

New book reveals promising nanomaterials for therapeutic drug delivery

'Nanomaterials: Evolution and Advancement Towards Therapeutic Drug Delivery' gives the present status and future perspective of Polymeric nanoparticles, Liposomes, Carbon Nanotubes, Magnetic Nanoparticles, Silica Based nanomaterial, Hydrogels, Metallic Nanoparticles, Cyclodextrins, Poly (Lactide-Co-Glycolide) and its Copolymers.

25 Jun 2021

Study reveals a novel trick employed by MRSA superbug to thwart the immune response

New research has uncovered a novel trick employed by the bacterium Staphylococcus aureus to thwart the immune response, raising hopes that a vaccine that prevents deadly MRSA infections is a little closer on the horizon.

25 Jun 2021

Scientists identify new virulence mechanism for a surface protein on pneumonia-causing bacteria

A bout with flu virus can be hard, but when Streptococcus pneumonia enters the mix, it can turn deadly.

24 Jun 2021

UCLA scientists discover how immune cells can be trained to fight potential threats

The body's immune cells naturally fight off viral and bacterial microbes and other invaders, but they can also be reprogrammed or "trained" to respond even more aggressively and potently to such threats, report UCLA scientists who have discovered the fundamental rule underlying this process in a particular class of cells.

24 Jun 2021

Is COVID-19 more severe in pregnancy?

A new study, released as a preprint on the medRxiv* server, indicates that pregnant women are more likely to develop severe disease following severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) infection.

24 Jun 2021

WHO, COVAX partners work with South African consortium to build COVID-19 vaccine technology transfer hub

The World Health Organization and its COVAX partners are working with a South African consortium comprising Biovac, Afrigen Biologics and Vaccines, a network of universities and the Africa Centres for Disease Control and Prevention (CDC) to establish its first COVID mRNA vaccine technology transfer hub.

24 Jun 2021

Could polio vaccines induce cross-reactive antibodies that target SARS-CoV-2?

A new preprint released on the medRxiv* server explores a link between immunity to SARS-CoV-2, the earlier SARS-CoV, and childhood poliovirus vaccination. Almost 90% of the world’s people have received this vaccine, but antibodies elicited by it reduce over time and are almost absent at the end of adolescence.

24 Jun 2021

Vaccine News and Research

Latest Vaccine News and Research

Swedish study reveals how long immunity lasts after mild COVID

Oxford study sheds light on level of antibodies needed to protect against COVID-19 symptoms

Lambda lineage of SARS-CoV-2 has potential to become variant of concern

Georgia Tech’s dashboard breaks down Covid-19 vaccination trends by race at county level

New insights on how an important class of immune receptors are activated

Structural studies of SARS-CoV-2 spike protein reveal new properties of Alpha and Beta variants

New positive data on BCG’s ability to safely and significantly lower blood sugars

Researchers determine molecular structure of bacterial protein complex critical for tuberculosis

UNC study provides important information for developing a viable vaccine against dengue

Novel biosensor offers rapid quantitative variant of concern-independent serology for SARS-CoV-2

Study examines safety of COVID-19 vaccination during lactation

The WHO didn’t reverse its position on kids and Covid vaccines

Evaluation of COVID-19 vaccination effects on outbreak dynamics in Japan

New book reveals promising nanomaterials for therapeutic drug delivery

Study reveals a novel trick employed by MRSA superbug to thwart the immune response

Scientists identify new virulence mechanism for a surface protein on pneumonia-causing bacteria

UCLA scientists discover how immune cells can be trained to fight potential threats

Is COVID-19 more severe in pregnancy?

WHO, COVAX partners work with South African consortium to build COVID-19 vaccine technology transfer hub

Could polio vaccines induce cross-reactive antibodies that target SARS-CoV-2?

Event guide: 3rd mRNA Process Development & Manufacturing Europe eBook

How the Vutara VXL simplifies single-molecule imaging

How cohesin mechanics and nanotracker tech are redefining DNA research

Todd Bauman and Chris Povich

Vaccine News and Research

Latest Vaccine News and Research

Event guide: 3rd mRNA Process Development & Manufacturing Europe eBook

How the Vutara VXL simplifies single-molecule imaging

How cohesin mechanics and nanotracker tech are redefining DNA research

Todd Bauman and Chris Povich

Newsletters you may be interested in